Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Glioblastoma 7Recurrence 2Prostatic Neoplasms 2Brain Neoplasms 2Astrocytoma 2Optic Nerve Glioma 1Oligodendroglioma 1Metatropic dwarfism 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Gliosarcoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cytarabine 8Peripheral Blood Stem Cell Transplantation 3Idarubicin 3Filgrastim 2Daunorubicin 2Clofarabine 2tipifarnib 1temsirolimus 1sargramostim 1laromustine 1eltrombopag 1alvocidib 1aldesleukin 1Whole-Body Irradiation 1Radiotherapy 1Proto-Oncogene Proteins c-kit 1Polymerase Chain Reaction 1Mitoxantrone 1Melphalan 1Lenalidomide 1Injections 1Imatinib Mesylate 1Gene Expression Profiling 1Gemtuzumab 1Flow Cytometry 1Etoposide 1Decitabine 1Cyclosporine 1Cyclophosphamide 1Cilengitide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Basophilic, Acute × Cilengitide × Clear all
NCT00089388 2013-01-24

Cilengitide in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
70 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡